Ameloblastoma risk factors: Difference between revisions
Farima Kahe (talk | contribs) No edit summary |
|||
| Line 22: | Line 22: | ||
Less common risk factors in the development of [[ameloblastoma]] include: | Less common risk factors in the development of [[ameloblastoma]] include: | ||
* [[Infection|Infections]] by [[viruses]] | |||
* Lack of [[protein]] or [[minerals]] in the [[diet]] | |||
==References== | ==References== | ||
Revision as of 13:11, 23 October 2018
|
Ameloblastoma Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ameloblastoma risk factors On the Web |
|
American Roentgen Ray Society Images of Ameloblastoma risk factors |
|
Risk calculators and risk factors for Ameloblastoma risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2] Vamsikrishna Gunnam M.B.B.S [3]
Overview
There are no established risk factors for ameloblastoma. It is thought that common risk factors in the development of ameloblastoma may be dentigerous cyst, impacted teeth, injury to the mouth or jaw, infections of the teeth or gums, inflammation of the teeth or gums, infections by viruses, and lack of protein or minerals in the person's diet, and Gorlin-Goltz syndrome.
Risk Factors
There are no established risk factors for ameloblastoma.
Common Risk Factors
- The risk factors of ameloblastoma is not well understood.[1][2]
- Risk factors may include the following:
- Dentigerous cyst
- Impacted teeth
- Injury to the mouth or jaw
- Infections of the teeth or gums
- Inflammation of the teeth or gums
Less Common Risk Factors
Less common risk factors in the development of ameloblastoma include:
- Infections by viruses
- Lack of protein or minerals in the diet
References
- ↑ Kreppel, M; Zöller, J (2018). "Ameloblastoma-Clinical, radiological, and therapeutic findings". Oral Diseases. 24 (1–2): 63–66. doi:10.1111/odi.12702. ISSN 1354-523X.
- ↑ Laborde, A.; Nicot, R.; Wojcik, T.; Ferri, J.; Raoul, G. (2017). "Ameloblastoma of the jaws: Management and recurrence rate". European Annals of Otorhinolaryngology, Head and Neck Diseases. 134 (1): 7–11. doi:10.1016/j.anorl.2016.09.004. ISSN 1879-7296.